# Intradermal LPS and Antibiotics

> **NCT03779360** · NA · COMPLETED · sponsor: **Centre for Human Drug Research, Netherlands** · enrollment: 32 (actual)

## Conditions studied

- Inflammation; Skin

## Interventions

- **DRUG:** Erythromycin 4% topical gel formulation:
- **DRUG:** Clindamycin 1% lotion formulation:
- **DRUG:** Prednisolone tablet (0.5mg/kg; parallel comparison):
- **DRUG:** Clobetasol propionate 0.05% topical formulation (crossover comparison):
- **OTHER:** Lipopolysaccharide

## Key facts

- **NCT ID:** NCT03779360
- **Lead sponsor:** Centre for Human Drug Research, Netherlands
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-12
- **Primary completion:** 2019-02-23
- **Final completion:** 2019-02-23
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2021-08-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03779360

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03779360, "Intradermal LPS and Antibiotics". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03779360. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*